 | Up a level |
Nichols, Wright W, Newell, Paul, Critchley, Ian A, Riccobene, Todd and Das, Shampa 
ORCID: 0000-0002-2540-4816
(2018)
Avibactam Pharmacokinetic/Pharmacodynamic Targets.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62 (6).
e02446-e02417.
Nichols, Wright W, Stone, Gregory G, Newell, Paul, Broadhurst, Helen, Wardman, Angela, MacPherson, Merran, Yates, Katrina, Riccobene, Todd, Critchley, Ian A and Das, Shampa ORCID: 0000-0002-2540-4816
(2018)
Ceftazidime-Avibactam Susceptibility Breakpoints Against Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrobial Agents and Chemotherapy, 62 (11).
e02590-e02517.
Das, Shampa ORCID: 0000-0002-2540-4816, Li, Jianguo, Riccobene, Todd, Carrothers, Timothy J, Newell, Paul, Melnick, David, Critchley, Ian A, Stone, Gregory G and Nichols, Wright W
(2019)
Dose Selection and Validation for Ceftazidime-Avibactam in Adults with Complicated Intra-abdominal Infections, Complicated Urinary Tract Infections, and Nosocomial Pneumonia.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (4).
e02187-e02118.
Das, Shampa ORCID: 0000-0002-2540-4816, Zhou, Diansong, Nichols, Wright W, Townsend, Andy, Newell, Paul and Li, Jianguo
(2020)
Selecting the dosage of ceftazidime-avibactam in the perfect storm of nosocomial pneumonia.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 76 (3).
pp. 349-361.